A phosphokinome-based screen uncovers new drug synergies for cancer driven by liver-specific gain of nononcogenic receptor tyrosine kinases.
about
A phosphokinome-based screen uncovers new drug synergies for cancer driven by liver-specific gain of nononcogenic receptor tyrosine kinases.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
A phosphokinome-based screen u ...... nic receptor tyrosine kinases.
@en
A phosphokinome-based screen u ...... nic receptor tyrosine kinases.
@nl
type
label
A phosphokinome-based screen u ...... nic receptor tyrosine kinases.
@en
A phosphokinome-based screen u ...... nic receptor tyrosine kinases.
@nl
prefLabel
A phosphokinome-based screen u ...... nic receptor tyrosine kinases.
@en
A phosphokinome-based screen u ...... nic receptor tyrosine kinases.
@nl
P2093
P2860
P50
P356
P1433
P1476
A phosphokinome-based screen u ...... enic receptor tyrosine kinases
@en
P2093
Emanuela Morenghi
Fabrice Daian
Guillaume Morcrette
Julien Calderaro
Massimo Roncalli
Matteo Donadon
Rosanna Dono
Sylvie Richelme
Yannan Fan
P2860
P304
P356
10.1002/HEP.29304
P407
P577
2017-09-29T00:00:00Z